Xuxinyi Ling
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer.
Journal: Translational oncology
Published: September 21, 2024
A nomogram model for predicting the risk of checkpoint inhibitor-related pneumonitis for patients with advanced non-small-cell lung cancer.
Journal: Cancer medicine
Published: December 02, 2022
A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells.
Journal: Cancers
Published: August 01, 2022
The predictive value of plasma exosomal lncRNAs/mRNAs in NSCLC patients receiving immunotherapy.
Journal: Advances in medical sciences
Published: July 27, 2022
A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer.
Journal: Translational lung cancer research
Published: October 20, 2021
Clinical value of an electromagnetic navigation system for CT-guided percutaneous lung biopsy of peripheral lung lesions.
Journal: Journal of thoracic disease
Published: March 09, 2021
Tumor genomics and response to chemotherapy in advanced non-small cell lung cancer with exon 20 insertion epidermal growth factor receptor mutations.
Journal: Annals of translational medicine
Published: November 19, 2020
The genomic characteristics of different progression patterns in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Journal: Annals of translational medicine
Published: October 14, 2020
Prognostic Implication of the Expression Level of PECAM-1 in Non-small Cell Lung Cancer.
Journal: Frontiers in oncology
Published: July 27, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026